The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections

The estimated incidence of pertussis in people aged 50 years old in the United States, 2006–2010

(2015) Cristina Masseria et al.   BMC INFECTIOUS DISEASES

Pertussis vaccines and the challenge of inducing durable immunity

(2015) Jason M Warfel et al.   CURRENT OPINION IN IMMUNOLOGY

Pertussis Across the Globe

(2015) Tina Tan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Loss of Multi-Epitope Specificity in Memory CD4+ T Cell Responses to B. Pertussis with Age

(2014) Wanda G. H. Han et al.   PLoS One

Age Related Differences in Dynamics of Specific Memory B Cell Populations after Clinical Pertussis Infection

(2014) Inonge van Twillert et al.   PLoS One

Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay

(2013) N. K. Fry et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Age-Related Differences in Patterns of Increased Bordetella pertussis Antibodies

(2012) Harry E. Prince et al.   Clinical and Vaccine Immunology

Two-Component Cluster Analysis of a Large Serodiagnostic Database for Specificity of Increases of IgG Antibodies against Pertussis Toxin in Paired Serum Samples and of Absolute Values in Single Serum Samples

(2012) Sabine C. de Greeff et al.   Clinical and Vaccine Immunology

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development and validation of an Australian in-house anti-pertussis toxin IgG and IgA enzyme immunoassay

(2012) Meryta L. May et al.   PATHOLOGY

Prospective Evaluation of an Australian Pertussis Toxin IgG and IgA Enzyme Immunoassay

(2011) Meryta L. May et al.   Clinical and Vaccine Immunology

Serum IgA Responses against Pertussis Proteins in Infected and Dutch wP or aP Vaccinated Children: An Additional Role in Pertussis Diagnostics

(2011) Lotte H. Hendrikx et al.   PLoS One

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

(2010) N. Guiso et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine

(2010) T. Dalby et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

(2010) Sabine C. de Greeff et al.   PLoS One

Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination withBordetella pertussisin young children

(2009) HANS O. HALLANDER et al.   APMIS

Estimating the Duration of Pertussis Immunity Using Epidemiological Signatures

(2009) Helen J. Wearing et al.   PLoS Pathogens

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus

(2008) Pieter G.M. van Gageldonk et al.   JOURNAL OF IMMUNOLOGICAL METHODS

European Sero-Epidemiology Network 2: Standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations

(2008) Anna Giammanco et al.   VACCINE